Can-Fite BioPharma Ltd.
CANF- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001536196
No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Can-Fite BioPharma Ltd. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 12 | 15 | +3 |
| Shares | 1.46M | 486.0K | −976.4K (−66.8%) |
| Value | $2.43M | $626.5K | −$1.80M (−74.2%) |
New holders (5)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 17,809 | $23.0K | 0.00% |
| HRT Financial LP | 11,900 | $15.0K | 0.00% |
| National Bank of Canada | 6,000 | $8.00K | 0.00% |
| Bank of America Corp | 499 | $1.00K | 0.00% |
| TD Waterhouse Canada Inc. | 203 | $354 | 0.00% |
Sold out (2)
Institutions that held Can-Fite BioPharma Ltd. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Armistice Capital, LLC | 875,000 | $1.45M |
| Renaissance Technologies LLC | 93,405 | $155.0K |